L-arginine
Performance

L-arginine

L-arginine is a proteinogenic amino acid that, under specific physiological conditions (growth, metabolic stress, illness), can become “conditionally essential.” In the performance context it is studied mainly as a precursor of nitric oxide (NO), a key molecule for vasodilation and the regulation of blood flow. Ergogenic efficacy in healthy adults is variable and depends on dose, timing, training status, and bioavailability limitations.

Semi-essential amino acid involved in nitric oxide (NO) synthesis and urea metabolism

L-Arginine

L-arginine is a proteinogenic amino acid that, under specific physiological conditions (growth, metabolic stress, illness), can become “conditionally essential.” In the performance context, it is studied primarily as a precursor to nitric oxide (NO), a key molecule for vasodilation and the regulation of blood flow. Ergogenic efficacy in healthy adults is variable and depends on dose, timing, training status, and bioavailability limitations.

Mechanism of action

1) NO pathway: L-arginine → (NOS) → NO + L-citrulline. NO activates soluble guanylate cyclase in vascular smooth muscle cells → ↑ cGMP → vasodilation and potential improvement in perfusion. 2) Competition with arginase: arginase converts arginine into ornithine + urea, reducing the amount available for NOS. 3) Urea cycle: supports the handling of nitrogen and ammonia, especially relevant in clinical conditions or metabolic stress. 4) Creatine precursor (indirect): contributes to endogenous creatine synthesis via guanidinoacetate, but the practical impact on muscle creatine in well-nourished individuals is generally limited compared with direct creatine supplementation.

Supported benefits

  • Improvement in endothelial function and vasodilation in individuals with endothelial dysfunction or cardiovascular risk factors (contexts not necessarily related to sports) (moderate)
  • Possible reduction in blood pressure in some individuals (small and variable average effect; more evident when elevated values or endothelial dysfunction are present) (moderate)
  • Aerobic/anaerobic performance in healthy adults: heterogeneous results; benefits not consistent in controlled studies, especially compared with alternatives such as L-citrulline (limited)
  • Support in specific clinical conditions (e.g., some forms of erectile dysfunction or post-operative recovery) as an adjunct, with variable and context-dependent evidence (limited)

Safety & side effects

  • Gastrointestinal disturbances (nausea, cramps, diarrhea, bloating), more frequent with high doses or single administrations
  • Headache or flushing (possibly related to vasodilation in sensitive individuals)
  • Possible reduction in blood pressure (dizziness/asthenia in predisposed individuals)
  • Rare: worsening of symptoms in individuals with asthma or bronchial hyperreactivity (reports are not consistent)

FAQ

Why does L-arginine sometimes “not work” for pump or performance?

Because oral arginine can be partly metabolized in the intestine and liver (first-pass effect) and converted by arginase, reducing the amount available for NO synthesis. In addition, in healthy individuals the NO pathway may not be the limiting factor in performance.

Is L-citrulline different from L-arginine?

Yes. Citrulline is converted into arginine mainly in the kidneys and often increases plasma arginine more efficiently than arginine taken directly, which is why it is frequently preferred in studies on NO and performance.

Does L-arginine increase growth hormone (GH)?

In some studies, arginine may influence GH secretion under experimental conditions, but the effect is variable and does not automatically imply benefits for body composition or performance; the practical interpretation is limited.

Is it useful for blood pressure?

In some individuals, it may contribute to small improvements in blood pressure and endothelial function, especially when NO bioavailability is reduced. However, the effect is not guaranteed and may interact with antihypertensive therapies.

What are the signs of poor tolerance?

Gastrointestinal disturbances (diarrhea, cramps, nausea), dizziness, or a sensation of low blood pressure. In these cases, it is prudent to stop and consult a healthcare professional, especially if you are taking medications.

The information provided is for informational and educational purposes only. It does not constitute medical advice. Use must be evaluated and authorized by a qualified healthcare professional.

Mechanism of action

1) NO pathway: L-arginine → (NOS) → NO + L-citrulline. NO activates soluble guanylate cyclase in vascular smooth muscle cells → ↑ cGMP → vasodilation and potential improvement in perfusion. 2) Competition with arginase: arginase converts arginine into ornithine + urea, reducing the amount available for NOS. 3) Urea cycle: support for nitrogen and ammonia handling, especially relevant in clinical conditions or metabolic stress. 4) Creatine precursor (indirect): contributes to endogenous creatine synthesis via guanidinoacetate, but the practical impact on muscle creatine in well-nourished individuals is generally limited compared with direct creatine supplementation.

Scientific benefits

Improvement of endothelial function and vasodilation in individuals with endothelial dysfunction or cardiovascular risk factors (contexts not necessarily related to sports)
Evidence level: moderate
Possible reduction in blood pressure in some individuals (small and variable average effect; more evident in the presence of elevated values or endothelial dysfunction)
Evidence level: moderate
Aerobic/anaerobic performance in healthy adults: mixed results; benefits are not consistent in controlled studies, especially compared with alternatives such as L-citrulline
Evidence level: limited
Support in specific clinical conditions (e.g. some forms of erectile dysfunction or post-operative recovery) as an adjunct, with variable and context-dependent evidence
Evidence level: limited

Contraindications

  • Pregnancy and breastfeeding: insufficient data for unsupervised use
  • Hypotension or tendency toward syncope
  • Unstable cardiovascular disease or recent cardiovascular events: clinical evaluation required (risk of hemodynamic effects and drug interactions)
  • Significant renal or hepatic insufficiency: possible alteration of nitrogen metabolism and the urea cycle; requires supervision
  • History of recurrent herpes simplex: arginine may promote viral replication in some contexts (evidence not definitive, but caution is commonly advised)
  • Peri-operative use: possible interference with blood pressure and hemodynamic management; discontinuation before surgery is often recommended according to clinical guidance

Side effects

  • Gastrointestinal disturbances (nausea, cramps, diarrhea, bloating), more frequent with high doses or single administration
  • Headache or flushing (possible correlation with vasodilation in sensitive individuals)
  • Possible reduction in blood pressure (dizziness/asthenia in predisposed individuals)
  • Rare: worsening of symptoms in individuals with asthma or bronchial hyperreactivity (reports are not consistent)

Interactions

  • Antihypertensive drugs: possible additive effect on blood pressure reduction
  • Nitrates (e.g. nitroglycerin) and NO donors: potential increase in the risk of hypotension
  • PDE5 inhibitors (e.g. sildenafil, tadalafil): possible summation of vasodilatory and hypotensive effects
  • Anticoagulants/antiplatelet agents: data are inconclusive; caution due to possible endothelial/vascular effects and comorbidities
  • Drugs that affect renal function or electrolyte balance: caution in vulnerable individuals

Regulatory status

Generally marketed as a dietary supplement (amino acid) in the EU and USA; it is not a prohibited substance on the main anti-doping lists as an ingredient, but multi-ingredient products may carry a risk of contamination/adulteration. Health indications/claims are regulated and vary by country.

Supplements and peptides

All supplements